Twelve-month resistance and impact exercise program or risedronate provides a relative benefit to hip bone structure in postmenopausal women: results from a randomized controlled trial
ConclusionExercise and bisphosphonates may influence structural and strength estimates at the hip, but not at peripheral sites (tibia). Neither exercise nor bisphosphonates were found to be superior in improving estimates of hip bone strength.
Source: Osteoporosis International - Category: Orthopaedics Source Type: research
More News: Actonel | Calcium | CT Scan | DEXA Scan | Men | Menopause | Orthopaedics | Osteoporosis | PET Scan | Risedronate | Sports Medicine | Study | Vitamin D | Vitamins | Women